Market Place
Filter By Unselect All
Sub Category Unselect See All
Clinical Supply (11)
Enteric Coated (1)
Hard Capsule (10)
Modified Release (9)
Oral (1)
Overview (46)
Vegetarian (1)
Country Unselect See All
Austria (1)
Belgium (2)
China (3)
Croatia (1)
Cyprus (1)
France (5)
Germany (4)
Greece (5)
India (11)
Ireland (2)
Italy (1)
Poland (2)
Portugal (3)
Romania (2)
Singapore (1)
Spain (3)
Sweden (1)
Switzerland (2)
United Kingdom (3)
United States (12)
Companies Unselect See All
AbbVie Contract (1)
Aenova Group (1)
AlbyPharma (1)
ANFARM HELLAS (1)
BILCARE GCS (1)
BIOLOGICAL E. (1)
Biopharma Srl (1)
Bliss Gvs Pharma (1)
Capsugel (1)
Catalent Pharma (1)
Chanelle Medical (1)
Custom Pharma (1)
Cyndea Pharma (1)
Delpharm Group (1)
Eurofins CDMO (1)
Famar S.A. (1)
Farbe Firma (1)
Flagship Biotech (1)
Fresenius Kabi (1)
Global Pharma CM (1)
HEBEI CHANGSHAN (1)
JGL d.d (1)
Lecifarma (1)
LGV (1)
Medichem S.A. (1)
Mithra CDMO (1)
Neuraxpharm (1)
Olive Healthcare (1)
One Pharma S.A (1)
Orchid Chemicals (1)
ORIT LABS LLC (1)
Piramal Pharma (1)
Polpharma (1)
Priyans Drugs (1)
R-Pharm Germany (1)
Rafarm S.A (1)
Recipharm AB (1)
Ropack Inc (1)
Santa S.A (1)
Servier CDMO (1)
Siegfried AG (1)
Sirio Pharma Co. (1)
Skyepharma (1)
Sofarimex (1)
The Madras (1)
Selected Filter(s): Reset All
- Category Reset
- Sub Category Reset
- Country Reset
Hard capsules Fillings Capacity 85,000,000 Per Year 
Drug Product Manufacturing >> Capsule >> Hard Capsule
Medichem Offers Contract Services for branded and generic products, In 2016, Medichem merged with Combino Pharm, which is devoted to the development and manufacture (licensing) of Finished Dosage Forms.
Website
Hard Gelatin Capsules
Drug Product Manufacturing >> Capsule >> Hard Capsule
Polpharma carries out contracted-out activities consisting in the manufacture of a wide range of solid dosage forms, including hard gelatin capsules.
Production of Capsules
Drug Product Manufacturing >> Capsule >> Overview
JGL was founded in Rijeka in 1991 as the first private pharmaceutical joint-stock company. Today, it offers products in nearly all technological forms and different legislative categories and operates in some forty foreign markets.
High-Potency Compounds Capsules Manufacturing
Drug Product Manufacturing >> Capsule >> High Potency APIs (HPAPIs)
Quotient Sciences has responded to the challenges associated with the manufacturing of today’s high-potency drug products by ensuring our facilities are capable of handling compounds with a maximum performance-based level of exposure classification.
Manufacturing of Capsules
Drug Product Manufacturing >> Capsule >> Overview
Biophore, an established pharmaceutical company, is engaged in the development and manufacturing of niche pharmaceutical products for the generic industry. Biophore has emerged as a trusted partner in the generic industry across US, Europe and other regulated markets.
Highly Potent / Cytotoxics Capsule Manufacturing
Drug Product Manufacturing >> Capsule >> High Potency APIs (HPAPIs)
Eurofins CDMO offers integrated development services through the entire drug product life cycle, from highly potent active pharmaceutical ingredients (HPAPI) forward.
Capsule Manufacturing For Controlled Substances
Drug Product Manufacturing >> Capsule >> Controlled Substance
Recro excels in the manufacture of complex products to your exact standards, with a specialization in extended release solid oral dose products and DEA controlled substances.
Manufacturing of Classic & Complex Capsule
Drug Product Manufacturing >> Capsule >> Overview
Single layer tablets, multi-layer tablets, tab-in-tab, tab-in-caps, hard gel capsules and sachets.
Capsules Production
Drug Product Manufacturing >> Capsule >> Overview
Development, manufacture and control of generic pharmaceutical specialties, both for Neuraxpharm and other laboratories, performed at Lesvi facilities in Sant Joan Despí (Barcelona), Spain
Clinical Trial Supply of Capsule
Drug Product Manufacturing >> Capsule >> Clinical Supply
Clinical trial supplies manufacturing according to GMP (Good Manufacturing Practices) for pharmaceutical products for use in Phase I and II clinical trials.